ArticleBMJ open2021

Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study.

Martine Hoogendoorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.